16 research outputs found
Age Related Changes in NAD+ Metabolism Oxidative Stress and Sirt1 Activity in Wistar Rats
The cofactor nicotinamide adenine dinucleotide (NAD+) has emerged as a key
regulator of metabolism, stress resistance and longevity. Apart from its role as
an important redox carrier, NAD+ also serves as the sole substrate for
NAD-dependent enzymes, including poly(ADP-ribose) polymerase (PARP), an
important DNA nick sensor, and NAD-dependent histone deacetylases, Sirtuins
which play an important role in a wide variety of processes, including
senescence, apoptosis, differentiation, and aging. We examined the effect of
aging on intracellular NAD+ metabolism in the whole heart, lung, liver and
kidney of female wistar rats. Our results are the first to show a significant
decline in intracellular NAD+ levels and NAD∶NADH ratio in all organs
by middle age (i.e.12 months) compared to young (i.e. 3 month old) rats. These
changes in [NAD(H)] occurred in parallel with an increase in lipid
peroxidation and protein carbonyls (o- and m- tyrosine) formation and decline in
total antioxidant capacity in these organs. An age dependent increase in DNA
damage (phosphorylated H2AX) was also observed in these same organs. Decreased
Sirt1 activity and increased acetylated p53 were observed in organ tissues in
parallel with the drop in NAD+ and moderate over-expression of Sirt1
protein. Reduced mitochondrial activity of complex I–IV was also observed
in aging animals, impacting both redox status and ATP production. The strong
positive correlation observed between DNA damage associated NAD+ depletion
and Sirt1 activity suggests that adequate NAD+ concentrations may be an
important longevity assurance factor
A Nationwide, Population-based Cohort Study on Potential Autoimmune Association of Ménière Disease to Atopy and Vitiligo
Pycnoscelus surinamensis (Linnaeus, 1758) (Blaberoidea: Blaberidae), a cockroach with a possible association with the ant Brachymyrmex cordemoyi Forel, 1895 (Hymenoptera: Formicidae) and which may be exhibiting a domiciliation trend.
Signs of atopic dermatitis and contact dermatitis affected by distinct H2-haplotype in the NC/Nga genetic background
Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)
Neuromyelitis optica (NMO, Devic's syndrome), long considered a clinical variant of multiple sclerosis, is now regarded as a distinct disease entity. Major progress has been made in the diagnosis and treatment of NMO since aquaporin-4 antibodies (AQP4-Ab; also termed NMO-IgG) were first described in 2004. In this review, the Neuromyelitis Optica Study Group (NEMOS) summarizes recently obtained knowledge on NMO and highlights new developments in its diagnosis and treatment, based on current guidelines, the published literature and expert discussion at regular NEMOS meetings. Testing of AQP4-Ab is essential and is the most important test in the diagnostic work-up of suspected NMO, and helps to distinguish NMO from other autoimmune diseases. Furthermore, AQP4-Ab testing has expanded our knowledge of the clinical presentation of NMO spectrum disorders (NMOSD). In addition, imaging techniques, particularly magnetic resonance imaging of the brain and spinal cord, are obligatory in the diagnostic workup. It is important to note that brain lesions in NMO and NMOSD are not uncommon, do not rule out the diagnosis, and show characteristic patterns. Other imaging modalities such as optical coherence tomography are proposed as useful tools in the assessment of retinal damage. Therapy of NMO should be initiated early. Azathioprine and rituximab are suggested as first-line treatments, the latter being increasingly regarded as an established therapy with long-term efficacy and an acceptable safety profile in NMO patients. Other immunosuppressive drugs, such as methotrexate, mycophenolate mofetil and mitoxantrone, are recommended as second-line treatments. Promising new therapies are emerging in the form of anti-IL6 receptor, anti-complement or anti-AQP4-Ab biologicals
Up-regulated expression of substance P in CD8+ T cells and NK1R on monocytes of atopic dermatitis
IgE autoantibodies and autoreactive T cells and their role in children and adults with atopic dermatitis
Mutation Processes in 293-Based Clones Overexpressing the DNA Cytosine Deaminase APOBEC3B
<div><p>Molecular, cellular, and clinical studies have combined to demonstrate a contribution from the DNA cytosine deaminase APOBEC3B (A3B) to the overall mutation load in breast, head/neck, lung, bladder, cervical, ovarian, and other cancer types. However, the complete landscape of mutations attributable to this enzyme has yet to be determined in a controlled human cell system. We report a conditional and isogenic system for A3B induction, genomic DNA deamination, and mutagenesis. Human 293-derived cells were engineered to express doxycycline-inducible A3B-eGFP or eGFP constructs. Cells were subjected to 10 rounds of A3B-eGFP exposure that each caused 80–90% cell death. Control pools were subjected to parallel rounds of non-toxic eGFP exposure, and dilutions were done each round to mimic A3B-eGFP induced population fluctuations. Targeted sequencing of portions of <i>TP53</i> and <i>MYC</i> demonstrated greater mutation accumulation in the A3B-eGFP exposed pools. Clones were generated and microarray analyses were used to identify those with the greatest number of SNP alterations for whole genome sequencing. A3B-eGFP exposed clones showed global increases in C-to-T transition mutations, enrichments for cytosine mutations within A3B-preferred trinucleotide motifs, and more copy number aberrations. Surprisingly, both control and A3B-eGFP clones also elicited strong mutator phenotypes characteristic of defective mismatch repair. Despite this additional mutational process, the 293-based system characterized here still yielded a genome-wide view of A3B-catalyzed mutagenesis in human cells and a system for additional studies on the compounded effects of simultaneous mutation mechanisms in cancer cells.</p></div
Mlh2 Is an Accessory Factor for DNA Mismatch Repair in Saccharomyces cerevisiae
In Saccharomyces cerevisiae, the essential mismatch repair (MMR) endonuclease Mlh1-Pms1 forms foci promoted by Msh2-Msh6 or Msh2-Msh3 in response to mispaired bases. Here we analyzed the Mlh1-Mlh2 complex, whose role in MMR has been unclear. Mlh1-Mlh2 formed foci that often colocalized with and had a longer lifetime than Mlh1-Pms1 foci. Mlh1-Mlh2 foci were similar to Mlh1-Pms1 foci: they required mispair recognition by Msh2-Msh6, increased in response to increased mispairs or downstream defects in MMR, and formed after induction of DNA damage by phleomycin but not double-stranded breaks by I-SceI. Mlh1-Mlh2 could be recruited to mispair-containing DNA in vitro by either Msh2-Msh6 or Msh2-Msh3. Deletion of MLH2 caused a synergistic increase in mutation rate in combination with deletion of MSH6 or reduced expression of Pms1. Phylogenetic analysis demonstrated that the S. cerevisiae Mlh2 protein and the mammalian PMS1 protein are homologs. These results support a hypothesis that Mlh1-Mlh2 is a non-essential accessory factor that acts to enhance the activity of Mlh1-Pms1